Serotonin Toxicity Association with Concomitant Antidepressants and Rasagiline Treatment: Retrospective Study (STACCATO)

Background The serotonin toxicity syndrome (STS) is a potential risk with concurrent use of the monoamine oxidase type‐B inhibitor rasagiline and antidepressants. Objective To assess systematically the occurrence of STS in patients with Parkinson disease (PD) treated with rasagiline plus antidepress...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Pharmacotherapy 2014-12, Vol.34 (12), p.1250-1258
Hauptverfasser:	Panisset, Michel, Chen, Jack J., Rhyee, Sean H., Conner, Jill, Mathena, Julie
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult and adolescent clinical studies Aged antidepressants Antidepressive Agents, Second-Generation - administration & dosage Antidepressive Agents, Second-Generation - adverse effects Biological and medical sciences Cohort Studies Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases Depression Drug Interactions Drug-Related Side Effects and Adverse Reactions Female Humans Indans - administration & dosage Indans - adverse effects Male Medical sciences Middle Aged Monoamine Oxidase Inhibitors - administration & dosage Monoamine Oxidase Inhibitors - adverse effects Mood disorders Nervous system (semeiology, syndromes) Nervous system as a whole Neurology Parkinson disease Parkinson Disease - drug therapy parkinsonism Pharmacology. Drug treatments Psychology. Psychoanalysis. Psychiatry Psychopathology. Psychiatry rasagiline Retrospective Studies Serotonin Uptake Inhibitors - administration & dosage Serotonin Uptake Inhibitors - adverse effects United States
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!